• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈萨克斯坦肺癌的流行病学:趋势和地理分布。

Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.

机构信息

Astana Medical University, Astana, Kazakhstan.

Central Asian Institute for Medical Research, Astana, Kazakhstan.

出版信息

Asian Pac J Cancer Prev. 2023 May 1;24(5):1521-1532. doi: 10.31557/APJCP.2023.24.5.1521.

DOI:10.31557/APJCP.2023.24.5.1521
PMID:37247271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10495898/
Abstract

OBJECTIVE

The aim is to study the trends of lung cancer (LC) incidence in the regional context in Kazakhstan.

METHODS

The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period.

RESULTS

Over the 10 years under study, 36,916 new cases of LC were registered in the country (80.5% - in men and 19.5% - in women). During the studied years the average age of patients was 64.2±0.1 years (95%CI=63.9-64.4). The highest incidence rates per 100,000 in the entire population were found in the age groups 65-69 years (147.6±2.7), 70-74 years (159.3±2.5), and 75-79 years (147.1±3.2). The incidence of LC tended to increase only at the age of 80-84 years (APC=+1.26) and the most pronounced average annual decline rates were observed in the age groups of 45-49 years (APC=-4.09), 50-54 years (APC=-4.20) and 85+ years (APC=-4.07). The average annual standardized incidence rate was 22.2 per 100,000, and in dynamics tended to decrease (APC=-2.04). There is a decrease in incidence in almost all regions, with the exception of the Mangystau region (APC=+1.65). During the compilation of cartograms, incidence rates were determined on the basis of standardized indicators: low - up to 20.6, average - from 20.6 to 25.6, high - above 25.6 per 100,000 for the entire population.

CONCLUSION

The incidence of lung cancer in Kazakhstan is decreasing. The incidence among the male population is six times higher than among the female, while the rate of decline is more pronounced. The incidence tends to decrease in almost all regions. High rates were found in the northern and eastern regions.

摘要

目的

研究哈萨克斯坦地区肺癌(LC)发病率的趋势。

方法

采用描述性和分析性肿瘤流行病学方法进行回顾性研究。根据卫生统计中普遍采用的方法,确定广泛、粗率和年龄特异性发病率。使用 Joinpoint 回归分析计算平均百分比变化(APC),以确定研究期间的趋势。

结果

在所研究的 10 年内,该国登记了 36916 例新的 LC 病例(80.5%为男性,19.5%为女性)。研究期间患者的平均年龄为 64.2±0.1 岁(95%CI=63.9-64.4)。整个人群中每 10 万人发病率最高的年龄组为 65-69 岁(147.6±2.7)、70-74 岁(159.3±2.5)和 75-79 岁(147.1±3.2)。LC 的发病率仅在 80-84 岁时呈上升趋势(APC=+1.26),而在 45-49 岁(APC=-4.09)、50-54 岁(APC=-4.20)和 85 岁以上(APC=-4.07)年龄组观察到最明显的平均年下降率。标准化发病率的平均年增长率为 22.2/10 万,且呈下降趋势(APC=-2.04)。除曼格斯套州外,几乎所有地区的发病率都有所下降(APC=+1.65)。在编制专题地图时,根据标准化指标确定发病率:低为 20.6 以下,中为 20.6-25.6,高为 25.6 以上/10 万,适用于整个人口。

结论

哈萨克斯坦的肺癌发病率正在下降。男性发病率是女性的六倍,而下降速度更为明显。发病率几乎在所有地区都呈下降趋势。高发病率出现在北部和东部地区。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/9d1c44de2756/APJCP-24-1521-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/a2c61df56a31/APJCP-24-1521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/93f15f640df4/APJCP-24-1521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/a1f398584bca/APJCP-24-1521-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/e2151087356c/APJCP-24-1521-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/c3d811064ece/APJCP-24-1521-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/82ddf14ab8f5/APJCP-24-1521-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/225d4b61835f/APJCP-24-1521-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/219dd8738351/APJCP-24-1521-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/9d1c44de2756/APJCP-24-1521-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/a2c61df56a31/APJCP-24-1521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/93f15f640df4/APJCP-24-1521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/a1f398584bca/APJCP-24-1521-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/e2151087356c/APJCP-24-1521-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/c3d811064ece/APJCP-24-1521-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/82ddf14ab8f5/APJCP-24-1521-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/225d4b61835f/APJCP-24-1521-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/219dd8738351/APJCP-24-1521-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411f/10495898/9d1c44de2756/APJCP-24-1521-g009.jpg

相似文献

1
Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.哈萨克斯坦肺癌的流行病学:趋势和地理分布。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1521-1532. doi: 10.31557/APJCP.2023.24.5.1521.
2
Lymphosarcoma Incidence in Kazakhstan: A Retrospective Survey (2010-2019).哈萨克斯坦淋巴肉瘤发病率:回顾性调查(2010-2019 年)。
Asian Pac J Cancer Prev. 2023 Jun 1;24(6):1885-1896. doi: 10.31557/APJCP.2023.24.6.1885.
3
Liver Cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study.哈萨克斯坦的肝癌发病率:十五年回顾性研究。
Asian Pac J Cancer Prev. 2024 May 1;25(5):1763-1775. doi: 10.31557/APJCP.2024.25.5.1763.
4
Epidemiology of Breast Cancer Mortality in Kazakhstan, trends and Geographic Distribution.哈萨克斯坦乳腺癌死亡率的流行病学,趋势和地理分布。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3361-3371. doi: 10.31557/APJCP.2023.24.10.3361.
5
Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019.哈萨克斯坦 2005-2019 年特定分期肾癌发病率趋势。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3239-3249. doi: 10.31557/APJCP.2024.25.9.3239.
6
Colorectal Cancer Mortality in Kazakhstan: Spatio-Temporal Epidemiological Assessment.哈萨克斯坦结直肠癌死亡率:时空流行病学评估。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):953-960. doi: 10.31557/APJCP.2022.23.3.953.
7
New Trends of Cervical Cancer Incidence in Kazakhstan.哈萨克斯坦宫颈癌发病率的新趋势。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1295-1304. doi: 10.31557/APJCP.2021.22.4.1295.
8
Trend in Gastric Cancer Mortality in Kazakhstan.哈萨克斯坦胃癌死亡率趋势。
Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3779-3789. doi: 10.31557/APJCP.2022.23.11.3779.
9
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.哈萨克斯坦子宫体癌:近期发病趋势。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):849-857. doi: 10.31557/APJCP.2023.24.3.849.
10
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.

引用本文的文献

1
Environmental risk assessment for sustainable industrial urban development: The case of northern industrial zone of Pavlodar, Kazakhstan.可持续工业城市发展的环境风险评估:以哈萨克斯坦巴甫洛达尔北部工业区为例。
PLoS One. 2025 Apr 16;20(4):e0320835. doi: 10.1371/journal.pone.0320835. eCollection 2025.
2
Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019.哈萨克斯坦 2005-2019 年特定分期肾癌发病率趋势。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3239-3249. doi: 10.31557/APJCP.2024.25.9.3239.

本文引用的文献

1
Lung Cancer 2020: Epidemiology, Etiology, and Prevention.肺癌 2020:流行病学、病因学和预防。
Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.
在全国肺癌筛查试验中,烟草依赖预示着更高的肺癌和死亡率以及更低的戒烟率。
Chest. 2018 Jul;154(1):110-118. doi: 10.1016/j.chest.2018.04.016. Epub 2018 May 21.
4
The health effects of radon and uranium on the population of Kazakhstan.氡和铀对哈萨克斯坦民众的健康影响。
Genes Environ. 2015 Oct 1;37:18. doi: 10.1186/s41021-015-0019-3. eCollection 2015.
5
Lung Cancer Statistics.肺癌统计数据。
Adv Exp Med Biol. 2016;893:1-19. doi: 10.1007/978-3-319-24223-1_1.
6
Particulate matter-induced epigenetic changes and lung cancer.颗粒物诱导的表观遗传变化与肺癌
Clin Respir J. 2017 Sep;11(5):539-546. doi: 10.1111/crj.12389. Epub 2015 Oct 20.
7
International variation in lung cancer mortality rates and trends among women.女性肺癌死亡率及趋势的国际差异。
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1025-36. doi: 10.1158/1055-9965.EPI-13-1220. Epub 2014 May 16.
8
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.肺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Mar 4;160(5):330-8. doi: 10.7326/M13-2771.
9
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
10
The impact of declining smoking on radon-related lung cancer in the United States.下降的吸烟率对美国氡相关肺癌的影响。
Am J Public Health. 2011 Feb;101(2):310-4. doi: 10.2105/AJPH.2009.189225.